Description
Repligen Corporation: Powering Innovation With Game-Changing FlowVPX & PAT Integration!
Repligen Corporation reported strong financial results for the second quarter of 2025, driven by a 17% organic non-COVID revenue growth, which is the highest rate since 2022. This growth was bolstered by several segments within the company, with Chromatography and Filtration leading the way. Demand for consumables remains healthy, and high-teens growth in capital equipment was noted, indicating a solid rebound and strong market interest.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
